Iteos Therapeutics Inc Capital Reinvestment Ratio
Iteos Therapeutics Inc capital reinvestment ratio. Iteos Therapeutics Inc (ITOS) has a Capital Reinvestment Ratio of 0.03x as of December 2024, meaning it reinvests 0% of its operating cash flow ($5.50 Million) in capital expenditures ($152.00K). Check cash flow reinvestment rate of Iteos Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Iteos Therapeutics Inc (2021–2021)
Capital reinvestment ratio of Iteos Therapeutics Inc from 2021 to 2021. This chart tracks Iteos Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore ITOS net asset momentum to track the company's year-over-year net asset growth rate.
Iteos Therapeutics Inc Capital Reinvestment Ratio by Year (2021–2021)
Iteos Therapeutics Inc capital reinvestment ratio by year from 2021 to 2021. For the full cash flow conversion analysis, see ITOS cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.00x | $513.14 Million | $1.18 Million | — |